Kamada (KMDA) Other Non-Current Assets (2012 - 2025)

Kamada (KMDA) posted quarterly Other Non-Current Assets of $1.4 million for Q4 2025, up 1163.39% year-on-year from $112000.0 in Q4 2024, and up 1163.39% on a QoQ basis from $112000.0 in Q4 2024.

Kamada (KMDA) Other Non-Current Assets (2012 - 2025) Analysis & Trends

Kamada (KMDA) has reported Other Non-Current Assets for 14 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Other Non-Current Assets rose 1163.39% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 1163.39% YoY) and the FY2025 annual result came in at $1.4 million, up 1163.39% from the prior year.
  • Other Non-Current Assets improved to $1.4 million in Q4 2025 per KMDA's latest filing, from $112000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for KMDA reached as high as $153.7 million in Q4 2021 and fell as low as $112000.0 in Q4 2024.
  • A 5-year average of $70.3 million and a median of $7.6 million in 2022 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2021 — Other Non-Current Assets soared 9668.79% — and 2022, when it sank 95.07%.
  • Year by year, Other Non-Current Assets stood at $153.7 million in 2021, then plunged by 95.07% to $7.6 million in 2022, then plunged by 93.27% to $510000.0 in 2023, then plunged by 78.04% to $112000.0 in 2024, then surged by 1163.39% to $1.4 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.4 million, $112000.0, and $510000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.42 Mn
Dec 31, 2024 112,000.00
Dec 31, 2023 510,000.00
Jun 30, 2023 143.99 Mn
Mar 31, 2023 145.31 Mn
Dec 31, 2022 7.58 Mn
Sep 30, 2022 148.62 Mn
Jun 30, 2022 150.45 Mn
Mar 31, 2022 151.86 Mn
Dec 31, 2021 153.66 Mn
Sep 30, 2021 3.38 Mn
Jun 30, 2021 3.41 Mn
Mar 31, 2021 3.18 Mn
Dec 31, 2020 1.57 Mn
Sep 30, 2020 1.08 Mn
Jun 30, 2020 1.06 Mn
Mar 31, 2020 1.05 Mn
Dec 31, 2019 352,000.00
Sep 30, 2019 178,000.00
Jun 30, 2019 174,000.00